HPS1 rs1804689: What Your Genotype Means

What each genotype means

Understanding the Variant

The variant rs1804689 is a single nucleotide polymorphism, which is a common type of genetic variation where a single "letter" of DNA—a nucleotide—differs between individuals. This specific SNP is located on chromosome 10. In the context of the human genome, rs1804689 is situated within the HPS1 gene region. Scientists track these variations using an rsID (reference SNP identification number) to ensure consistency across global research databases. While many SNPs have no observable effect on health, researchers study them to determine if they might influence biological processes or contribute to the risk of developing certain diseases. It is important to note that the presence of a specific variant does not mean an individual will develop a condition; rather, it is one of many factors, including environment and lifestyle, that contribute to human health.

The Role of the HPS1 Gene

The HPS1 gene provides instructions for making a protein that is part of a complex involved in the formation of specialized structures within cells called lysosomes and related organelles. These structures are essential for the proper function of various cell types, including those involved in pigmentation and blood clotting. Mutations in the HPS1 gene are primarily known for their role in Hermansky-Pudlak syndrome, a rare inherited disorder characterized by oculocutaneous albinism, bleeding problems, and sometimes lung or bowel disease. However, rs1804689 is a common variant, not a rare pathogenic mutation associated with this syndrome. Research into this specific SNP often focuses on whether common variations in this gene region might have subtle effects on cellular pathways that could influence more common, complex health outcomes, such as neurological or vascular health, though these links remain a subject of ongoing scientific investigation.

Research and Evidence Strength

The evidence linking rs1804689 to ischemic stroke and late-onset Alzheimer disease is considered limited. While some studies have explored these associations, the findings are not definitive. In complex diseases like stroke and Alzheimer's, thousands of genetic variants are often studied, and many reported associations are small or fail to be replicated in larger, more diverse populations. The "disease GWAS" (Genome-Wide Association Study) approach often identifies regions of interest, but these studies do not always pinpoint the exact functional variant or explain the biological mechanism behind a potential risk. Because the evidence for rs1804689 is not robust, it is not currently used in clinical settings to predict individual risk for these conditions. Readers should be cautious of interpreting this variant as a diagnostic tool, as the scientific community continues to refine its understanding of how such variants interact with other genetic and environmental factors.

Population Frequency

The variant rs1804689 is relatively common in the general population. According to data from large-scale genomic projects, the global minor allele frequency is approximately 0.3072. This means that a significant portion of the population carries at least one copy of the variant allele. Because it is common, it is considered a standard variation rather than a rare genetic anomaly. Frequency can vary significantly depending on ancestral background, which is a common observation in human genetics. Understanding these frequencies helps researchers determine if a variant is likely to be a neutral polymorphism or if it might have been influenced by evolutionary pressures. For the average person, the high frequency of this variant underscores that it is a normal part of human genetic diversity rather than an indicator of a specific health condition.

What This Information Means for You

If you have received information about your rs1804689 genotype, it is important to view it in the proper context. This variant is not a diagnostic marker for stroke or Alzheimer disease. Genetic predisposition is only one piece of a much larger puzzle that includes your age, family history, diet, physical activity, and overall medical history. You cannot use this information to predict your future health or to make medical decisions. If you are concerned about your risk for stroke or cognitive decline, the most effective steps involve consulting with a healthcare professional to discuss evidence-based screening and lifestyle modifications. Never change your medications or health habits based on a single genetic variant report. Always rely on guidance from your doctor or a qualified genetic counselor who can interpret your results alongside your complete clinical picture.

Frequently asked questions

Sources & further reading